STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - 10 months ended Dec. 31, 2021 - USD ($)	Redeemable Class A Common Stock Common Stock	Class B Common Stock Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Mar. 11, 2021				$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock to Sponsor		$ 431	$ 24,569	0	$ 25,000
Issuance of common stock to Sponsor (in shares)		4,312,500
Forfeiture of Founder Shares		$ (38)	38	0
Forfeiture of Founder Shares (in shares)		(387,500)
Proceeds from the sale of Class A common stock	$ 157,000,000			0
Proceeds from the sale of Class A common stock (in shares)	15,700,000
Paid underwriters fees	$ (3,140,000)			0
Deferred underwriting fees payable	(5,495,000)			0
Fair value of Public Warrants	(4,227,750)		4,227,750	0	4,227,750
Other offering costs	(201,621)		(267,873)	0	(267,873)
Share based compensation to Directors			187,115	0	187,115
Proceeds from the sale of private placement warrants			8,210,000	0	8,210,000
Accretion of Class A common stock to redemption value	14,634,371		$ (12,381,599)	(2,252,772)	(14,634,371)
Net Loss				(1,476,232)	(1,476,232)
Balance at the end at Dec. 31, 2021	$ 158,570,000	$ 393		$ (3,729,004)	$ (3,728,611)
Balance at the end (in shares) at Dec. 31, 2021	15,700,000	3,925,000